In Thursday’s Wall Street session, IGC Pharma Inc (AMEX:IGC) shares traded at $0.41, up 13.39% from the previous session.
IGC stock price is now 33.49% away from the 50-day moving average and 25.09% away from the 200-day moving average. The market capitalization of the company currently stands at $34.82M.
In other news, Moran James P, Director bought 588,235 shares of the company’s stock on Sep 25 ’24. The stock was bought for $200,000 at an average price of $0.34. Upon completion of the transaction, the Director now directly owns 942,402 shares in the company, valued at $0.39 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 12 ’24, Director PRINS RICHARD K bought 200,000 shares of the business’s stock. A total of $78,200 was incurred on buying the stock at an average price of $0.39. A total of 31.76% of the company’s stock is owned by insiders.
During the past 12 months, IGC Pharma Inc has had a low of $0.25 and a high of $0.50. As of last week, the company has a debt-to-equity ratio of 0.04, a current ratio of 1.28, and a quick ratio of 0.68. The fifty day moving average price for IGC is $0.3114 and a two-hundred day moving average price translates $0.33215 for the stock.
The latest earnings results from IGC Pharma Inc (AMEX: IGC) was released for 2025-03-31. The net profit margin was -560.27% and return on equity was -104.33% for IGC. The company reported revenue of $0.33 million for the quarter, compared to $0.29 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.86 percent.
